Granulocyte–macrophage CSF (GM-CSF) drives microglia-dependent glioma invasion in vitro, while mRNA expression of its gene CSF-2 has been inversely associated with patient survival in GBM [118]. This evidence concerns the gene CSF2 and central nervous system cancer.